Persistent URL of this record https://hdl.handle.net/1887/3762534
Documents
-
- Download
- s41523-023-00580-9
- Publisher's Version
-
open access
- Full text at publishers site
In Collections
This item can be found in the following collections:
High-dose alkylating chemotherapy in BRCA-altered triple-negative breast cancer: the randomized phase III NeoTN trial
Show less
- All authors
- Vliek, S.; Hilbers, F.S.; Werkhoven, E. van; Mandjes, I.; Kessels, R.; Kleiterp, S.; Lips, E.H.; Mulder, L.; Kayembe, M.T.; Loo, C.E.; Russell, N.S.; Peeters, M.J.T.F.D.V.; Holtkamp, M.J.; Schot, M.; Baars, J.W.; Honkoop, A.H.; Vulink, A.J.E.; Imholz, A.L.T.; Vrijaldenhoven, S.; Berkmortel, F.W.P.J. van den; Terwogt, J.M.M.; Schrama, J.G.; Kuijer, P.; Kroep, J.R.; Padt-pruijsten, A. van der; Wesseling, J.; Sonke, G.S.; Gilhuijs, K.G.A.; Jager, A.; Nederlof, P.; Linn, S.C.
- Date
- 2023-09-09
- Journal
- npj Breast Cancer
- Volume
- 9
- Issue
- 1